194 related articles for article (PubMed ID: 24140868)
1. Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.
Okada S; Kiyama T; Sato E; Tanaka Y; Oizumi T; Kuroishi T; Takahashi T; Sasaki K; Sugawara S; Endo Y
Tohoku J Exp Med; 2013 Oct; 231(2):145-58. PubMed ID: 24140868
[TBL] [Abstract][Full Text] [Related]
2. Phosphonocarboxylates Can Protect Mice against the Inflammatory and Necrotic Side Effects of Nitrogen-Containing Bisphosphonates by Inhibiting Their Entry into Cells via Phosphate Transporters.
Kiyama T; Tsuchiya M; Okada S; Oizumi T; Yamaguchi K; Sasaki K; Sugawara S; Endo Y
Biol Pharm Bull; 2016; 39(5):712-20. PubMed ID: 27150143
[TBL] [Abstract][Full Text] [Related]
3. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
Endo Y; Funayama H; Yamaguchi K; Monma Y; Yu Z; Deng X; Oizumi T; Shikama Y; Tanaka Y; Okada S; Kim S; Kiyama T; Bando K; Shima K; Suzuki H; Takahashi T
Yakugaku Zasshi; 2020; 140(1):63-79. PubMed ID: 31902887
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate).
Suzuki H; Bando K; Tada H; Kiyama T; Oizumi T; Funayama H; Sugawara S; Takahashi T; Endo Y
Biol Pharm Bull; 2019; 42(2):164-172. PubMed ID: 30713248
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Effects of Nitrogen-Containing Bisphosphonates (N-BPs): Modulation by Non-N-BPs.
Shima K; Tsuchiya M; Oizumi T; Takano-Yamamoto T; Sugawara S; Endo Y
Biol Pharm Bull; 2017; 40(1):25-33. PubMed ID: 28049945
[TBL] [Abstract][Full Text] [Related]
6. The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways.
Shima K; Nemoto W; Tsuchiya M; Tan-No K; Takano-Yamamoto T; Sugawara S; Endo Y
Biol Pharm Bull; 2016; 39(5):770-7. PubMed ID: 27150146
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
Oizumi T; Funayama H; Yamaguchi K; Yokoyama M; Takahashi H; Yamamoto M; Kuroishi T; Kumamoto H; Sasaki K; Kawamura H; Sugawara S; Endo Y
J Oral Maxillofac Surg; 2010 May; 68(5):1043-54. PubMed ID: 20156665
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and necrotic effects of minodronate, a nitrogen-containing bisphosphonate, in mice.
Kiyama T; Okada S; Tanaka Y; Kim S; Bando K; Hasegawa M; Yamaguchi K; Takano-Yamamoto T; Sasaki K; Sugawara S; Endo Y
Tohoku J Exp Med; 2013 Jul; 230(3):141-9. PubMed ID: 23822921
[TBL] [Abstract][Full Text] [Related]
9. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
Oizumi T; Yamaguchi K; Funayama H; Kuroishi T; Kawamura H; Sugawara S; Endo Y
Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
[TBL] [Abstract][Full Text] [Related]
10. Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Endo Y; Kumamoto H; Nakamura M; Sugawara S; Takano-Yamamoto T; Sasaki K; Takahashi T
Biol Pharm Bull; 2017; 40(6):739-750. PubMed ID: 28566618
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
Funayama H; Ohsako M; Monma Y; Mayanagi H; Sugawara S; Endo Y
Calcif Tissue Int; 2005 Jun; 76(6):448-57. PubMed ID: 15895282
[TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone.
Kim S; Seiryu M; Okada S; Kuroishi T; Takano-Yamamoto T; Sugawara S; Endo Y
Eur J Pharmacol; 2013 Jan; 699(1-3):14-22. PubMed ID: 23201069
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of N-bisphosphonate in osteoblastic cells mitigated by non-N-bisphosphonate but not by sodium-dependent phosphate cotransporter inhibitor.
Baba TT; Miyazaki T; Ohara-Nemoto Y; Nemoto TK
Cell Biochem Funct; 2019 Aug; 37(6):400-407. PubMed ID: 31328801
[TBL] [Abstract][Full Text] [Related]
14. Effects of Zoledronate on Local and Systemic Production of IL-1β, IL-18, and TNF-α in Mice and Augmentation by Lipopolysaccharide.
Funayama H; Tashima I; Okada S; Ogawa T; Yagi H; Tada H; Wakita R; Asada Y; Endo Y
Biol Pharm Bull; 2019; 42(6):929-936. PubMed ID: 31155589
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
16. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of bisphosphonates.
Reszka AA; Rodan GA
Curr Osteoporos Rep; 2003 Sep; 1(2):45-52. PubMed ID: 16036064
[TBL] [Abstract][Full Text] [Related]
19. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
Oizumi T; Yamaguchi K; Sato K; Takahashi M; Yoshimura G; Otsuru H; Tsuchiya M; Hagiwara Y; Itoi E; Sugawara S; Takahashi T; Endo Y
Biol Pharm Bull; 2016; 39(9):1549-54. PubMed ID: 27582334
[TBL] [Abstract][Full Text] [Related]
20. Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
Yu Z; Funayama H; Deng X; Kuroishi T; Sasano T; Sugawara S; Endo Y
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):222-9. PubMed ID: 16176557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
